Fam-trastuzumab deruxtecan-nxki for injection, for intravenous use Initial U.S. Approval: 2019.Fam-trastuzumab deruxtecan contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Fam-trastuzumab deruxtecan is a type of antibody-drug conjugate.
Are you looking for or in search of FDA approved “Fam-trastuzumab deruxtecan-nxki injection in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Breast Cancer. Need Access of Fam-trastuzumab deruxtecan-nxki injection, get in touch with our healthcare professional.
Fam-trastuzumab deruxtecan-nxki injection is used to treat HER2-positive metastatic (cancer that has spread to other parts of the body) breast cancer or whose cancer cannot be removed with surgery in patients who have previously received an anti-HER2 breast cancer treatment for metastatic disease or have breast cancer.